Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index; 9 of the 16 sources its claims cite were checked for support.

Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples

Open access
Marland, Victoria, Nisbet, Lorna, Nic Daéid, Niamh · 2025 · Harm Reduction Journal

Abstract

BACKGROUND: The detection of nitazene compounds in the United Kingdom has raised concerns among healthcare professionals, public health authorities, and law enforcement due to the increased risk of fatal overdose, particularly among opioid users. In response, nitazene testing strips have been distributed to help users identify these substances in drugs they may consume. However, to date, limited testing has been conducted on the effectiveness of these strips. METHODS: This study assesses the sensitivity and selectivity of a widely distributed nitazene immunoassay drug testing strip. The limit of detection and selectivity was examined for 36 nitazene analogs and 93 other drugs and cutting agents commonly encountered in illicit samples. The effectiveness of the test strips for the detection of metonitazene in the presence of other drugs was examined using a series of concentrations in solution in combination with other drugs. Testing of the strips was also carried out using authentic seized heroin samples. RESULTS: The strips detected 28 out of 36 nitazene compounds (78%) with detection limits ranging from 250 ng/mL to 100 µg/mL. The strips did not provide positive results for 93 other drugs and cutting agents at a concentration of 100 µg/mL. However, false positives were observed when testing seized heroin samples, caused by caffeine concentrations over 300 µg/mL. False negatives were also seen for eight nitazene compounds. CONCLUSION: Caution should be exercised when deploying these nitazene test strips as frontline presumptive tests in both criminal justice and public health contexts due to the observed false negative and false positive results. While the strips successfully detected a majority of nitazene compounds, their inability to identify certain analogs poses a risk of not detecting the presence of these potent opioids in the drug supply. Additionally, the occurrence of false positives, due to the presence of caffeine-a common adulterant in illicit substances-raises concerns about their suitability for use as a harm reduction method.

Overview

CoChat Summary

TL;DR

This laboratory evaluation found that BTNX Rapid Response™ nitazene test strips detected 28 of 36 nitazene analogs (78%) but missed eight and showed caffeine-related false positives with seized heroin samples. The authors caution that false negatives, variable limits of detection, and caffeine cross-reactivity limit the strips’ suitability as frontline presumptive tests in harm reduction and criminal justice settings.

Key findings

  • The strips detected 28/36 nitazene compounds (78%), with limits of detection ranging from 250 ng/mL to 100 µg/mL; eight nitazenes were not detected, including etazene, metodesnitazene, protodesnitazene, and 5-aminoisotonitazene.
  • No positive results were produced for 93 other drugs and cutting agents at 100 µg/mL, and metonitazene at 1300 ng/mL was detected in all mixtures containing 100 µg/mL of the listed drugs/cutting agents.
  • Seized heroin samples contained no nitazenes by GC–MS but produced faded test lines; caffeine cross-reactivity began at approximately 300 µg/mL and caused a false positive between 7 and 10 mg/mL. Estimated caffeine content in the seized samples was 21.9–24.7%, corresponding to 262–321 µg/mL in the 1 mg/mL test solutions.
  • Study LODs were 1500 ng/mL for isotonitazene, 3000 ng/mL for protonitazene HCl, and 1500 ng/mL for N-pyrrolidino etonitazene, compared with manufacturer-reported values of 2000, 3000, and 1300 ng/mL, respectively.

Methods

  • The study evaluated Rapid Response™ Nitazene Test Strips (BTNX, lots DOAB24050015 and DOAB24020005) using tap water; 36 nitazene analogs and 93 other drugs/cutting agents were tested at 100 µg/mL, and LODs were determined by serial 1-in-2 dilutions tested in triplicate, with LOD defined as the lowest concentration at which all replicates were positive.
  • Metonitazene detection in mixtures was assessed at 1300 ng/mL with 100 µg/mL of other compounds, and three authentic seized heroin samples from the Scottish Prison Service were dissolved at 1 mg/mL and tested, with GC–MS data used to confirm absence of nitazenes.
  • Test strips were read visually according to manufacturer instructions: one visible line was positive, two lines negative, and invalid strips were repeated.

Limitations

  • The paper states that limited access to authentic seized samples containing nitazenes meant the strips could not be evaluated with such materials; the drug panel reflected the UK illicit market, so cross-reactivity with all potential compounds was not assessed, and further assessment is needed as additional nitazenes emerge.
  • The text makes evident that visual interpretation of faint test lines is subjective and may be difficult in harm reduction settings, where image-processing aids such as ImageJ are described as unrealistic.
  • The paper cites prior work showing batch-to-batch LOD variation, but this study does not report lot-specific comparisons despite using two strip lots.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12954-025-01287-9

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Examples of positive and negative test strip results
Fig. 1 Examples of positive and negative test strip resultsCC BY · PubMed Central
Fig. 2 Images of testing strips following the analysis of 3 seized heroin samples from Scottish prisons. Each test trip displays a faded test line (indicated by black colored arrows), suggesting a degree of cross reactivity with the test strip and the seized samples
Fig. 2 Images of testing strips following the analysis of 3 seized heroin samples from Scottish prisons. Each test trip displays a faded test line (indicated by black colored arrows), suggesting a degree of cross reactivity with the test strip and the seized samplesCC BY · PubMed Central
Fig. 3 Images of testing strips following the analysis of 2 mg/mL solutions of diamorphine (base), 6-acetylcodeine hydrochloride, papaverine hydrochloride, noscapine (base), paracetamol and caffeine. The caffeine test strip displays a faded test line (indicated by black colored arrow), suggesting a degree of cross reactivity with the test strip and caffeine
Fig. 3 Images of testing strips following the analysis of 2 mg/mL solutions of diamorphine (base), 6-acetylcodeine hydrochloride, papaverine hydrochloride, noscapine (base), paracetamol and caffeine. The caffeine test strip displays a faded test line (indicated by black colored arrow), suggesting a degree of cross reactivity with the test strip and caffeineCC BY · PubMed Central
Fig. 4 Images of testing strips following the analysis of a series of caffeine concentrations. The test line begins to fade at a concentration of 300 µg/mL
Fig. 4 Images of testing strips following the analysis of a series of caffeine concentrations. The test line begins to fade at a concentration of 300 µg/mLCC BY · PubMed Central
Fig. 5 Images of testing strips following the analysis of an opiate/paracetamol mix with and without caffeine. The solution containing caffeine displays a faded test strip line
Fig. 5 Images of testing strips following the analysis of an opiate/paracetamol mix with and without caffeine. The solution containing caffeine displays a faded test strip lineCC BY · PubMed Central
Fig. 6 Examples of structural differences in nitazene analogs and the effects on LOD
Fig. 6 Examples of structural differences in nitazene analogs and the effects on LODCC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 7 Not valid · 7 Not checked · 49 Own results and interpretations

40 more claims · 1 with their cited sources checked

Create a free account to see all 65 claims and to verify the 2 references still open.

See all claims — free account
  • Probably not a substantial claim. 11
  • It may state two separate claims as one. 9
  • The quote only partly states this claim. 3

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 19 references

Cited by

See all 21

Metadata

Authors
Marland, V., Nisbet, L., & Nic Daéid, N.
Affiliations
University of Dundee (GB)
Corresponding author
Marland, Victoria
Venue
Harm Reduction Journal
Published
2025-08-09
Volume
22
Issue
1
Pages
137-137
ISSN
1477-7517 (ISSN-L)
OpenAlex
W4413094431
Cited by
21
References
19
Citations by year
2026: 18 · 2025: 3
FWCI
10.89
Type
journal article
Language
en
Open access
Licence
Locations
  • Harm Reduction Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discovery Research Portal (University of Dundee) (acceptedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Scottish Prison Service (Procurement Reference 01865)
  • The Leverhulme Trust (RC-2015-011)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Pharmacological Effects and Assays
Keywords
nitazenes, opioid overdose risk, heroin adulteration, false positives, false-negative results, harm reduction
MeSH terms
Humans, Immunoassay, Reagent Strips, Sensitivity and Specificity, Illicit Drugs, Substance Abuse Detection, Limit of Detection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples. https://app.cochat.ai/papers/10.1186/s12954-025-01287-9
The paper
Marland, V., Nisbet, L., & Nic Daéid, N. (2025). Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples. Harm Reduction Journal. https://doi.org/10.1186/s12954-025-01287-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.